Pierre ArsèneGRAIL Divestment: Perspectives, Valuation and its Potential Impact on the Liquid Biopsy Field (2/2)Returning from #JPM24, this post is a continuation from my previous post where I provided background on GRAIL’s situation and discussed its…Jan 27Jan 27
Pierre ArsèneGRAIL Divestment: Perspectives, Valuation and its Potential Impact on the Liquid Biopsy Field (1/2)Holy Grail by DALL-EJan 4Jan 4
Pierre ArsèneAnalysing Exosome Biology Enables Breakthrough Diagnostic SolutionsFrom analysing exosome biology to developing nextgen liquid biopsy testsMar 25, 20221Mar 25, 20221
Pierre ArsèneMy Prediction: Novel Exosome Technologies Are Going to Transform HealthcareA new hope to transform the standard of careJan 6, 20211Jan 6, 20211
